Skip to Content

MYLAN 2150 (Meclofenamate Sodium 50 mg)

Pill with imprint MYLAN 2150 is Red, Capsule-shape and has been identified as Meclofenamate Sodium 50 mg. It is supplied by Mylan Pharmaceuticals Inc..

Meclofenamate is used in the treatment of pain; premenstrual dysphoric disorder; osteoarthritis; period pain; rheumatoid arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. FDA has not classified the drug for risk during pregnancy. Meclofenamate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2150

Meclofenamate sodium 50 mg MYLAN 2150
Meclofenamate sodium 50 mg MYLAN 2150  Front
Meclofenamate sodium 50 mg MYLAN 2150  Back
Meclofenamate sodium 50 mg MYLAN 2150

Meclofenamate Sodium

MYLAN 2150
50 mg
14.00 mm
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
FD&C Blue No. 1
magnesium stearate
microcrystalline cellulose
corn starch
FD&C Red No. 3
sodium lauryl sulfate
titanium dioxide
D&C Yellow No. 10
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.